3 Biotech

, 9:392 | Cite as

Inhibition of respiratory syncytial virus replication and suppression of RSV-induced airway inflammation in neonatal rats by colchicine

  • Nihong Lu
  • Yongrui Yang
  • Honglu Liu
  • Xiangli Ding
  • Yangbing Ou
  • Jiawei Xia
  • Yingrong DuEmail author
Original Article


The present study investigated the role of colchicine in the treatment of RSV infection. Treatment of BEAS-2B cells following RSV infection with colchicine caused a significant decrease in the number of viral plaques. In RSV-infected BEAS-2B cells’ treatment with colchicine leads to a significant up-regulation of both IFN-β1 and RIG-I genes. The levels of interleukin, NO, and MDA were suppressed in BEAS-2B cells infected with RSV by colchicine. The phosphorylation of Stat3, COX-2, and p38 was also suppressed significantly by colchicine. The phosphorylation of IkBα was promoted in RSV-infected BEAS-2B cells’ oncolchicine treatment. In neonatal rats, replication of RSV was inhibited significantly by colchicine treatment which was evident by suppression of RSV-L gene expression. A significant decrease in the level of IL-6 and TNF-α was caused in neonatal rat BALF by colchicine treatment. The production of MDA, NO and MPO in the neonatal rat BALF was suppressed markedly by colchicine treatment. Treatment of the neonatal rats infected by RSV with colchicine suppressed the release of IκBα and COX-2 in the pulmonary epithelial cells. Colchicine treatment of the neonatal rats promoted the expression of IFN-α and IFN-β1. In summary, the current study showed that colchicine inhibited RSV infection in neonatal rats through regulation of anti-oxidative factor production. The expression of IFN-β1 and RIG-I genes was also up-regulated in the RSV-infected alveolar epithelial cells by treatment with colchicine. Therefore, colchicine may be developed as the therapeutic agent for the treatment of RSV infection.


Bronchiolitis Pneumonia Anti-oxidant Inflammation Microtubule 



This study was supported by Projects in Yunnan Science and Technology Plan (No: 2017FB147).


  1. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM (2002) Critical role for CXCR1 and CXCR1 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 110:1703–1716CrossRefGoogle Scholar
  2. Collins PL, Graham BS (2008) Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82:2040–2055CrossRefGoogle Scholar
  3. Disel U, Paydas S, Dogan A, Gulfiliz G, Yavuz S (2004) Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF–beta overexpression, apoptosis, and oxidative damage: an experimental animal study. Transpl Proc 36:1372–1376CrossRefGoogle Scholar
  4. Feng Q, Su Z, Song S, Χu H, Zhang B, Yi L, Tian M, Wang H (2016) Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation. Int J Mol Med 38:812–822CrossRefGoogle Scholar
  5. Guan T, Gao B, Chen G, Chen X, Janssen M, Uttarwar L, Ingram AJ, Krepinsky JC (2013) Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease. Am J Physiol Renal Physiol 305:F1466–F1476CrossRefGoogle Scholar
  6. Hall CB, Geiman JM, Biggar R, Kotok DI, Hogan PM, Douglas GR Jr (1976) Respiratory syncytial virus infections within families. N Engl J Med 294:414–419CrossRefGoogle Scholar
  7. Hastie SB (1991) Interactions of colchicine with tubulin. Pharmacol Ther 51:377–401CrossRefGoogle Scholar
  8. Hosakote YM, Komaravelli N, Mautemps N, Liu T, Garofalo RP, Casola A (2012) Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 303:L991–L1000CrossRefGoogle Scholar
  9. Icardi L, Lievens S, Mori R, Piessevaux J, De Cauwer L, De Bosscher K, Tavernier J (2012) Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J 26:240–249CrossRefGoogle Scholar
  10. Jamaluddin M, Tian B, Boldogh I, Garofalo RP, Brasier AR (2009) Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression. J Virol 83:10605–10615CrossRefGoogle Scholar
  11. Jie YH, Cammisuli S, Baggiolini M (1984) Immunomodulatory effects of Panax Ginseng C.A. Meyer in the mouse. Agents Actions 15:386–391CrossRefGoogle Scholar
  12. Ledwozyw A (1994) The effect of colchicine and vinblastine on bleomycin–induced lung fibrosis in rats. Acta Physiol Hung 82:383–389PubMedGoogle Scholar
  13. Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, Kim SH, Han SH, Lee JE, Moon SJ et al (2009) Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol 297:F200–F209CrossRefGoogle Scholar
  14. McClurkin C Jr, Phan SH, Hsu CH, Patel SR, Spicker JK, Kshirsagar AM, Yuan WY, Wiggins RC (1990) Moderate protection of renal function and reduction of fibrosis by colchicine in a model of anti–GBM disease in the rabbit. J Am Soc Nephrol 1:257–265PubMedGoogle Scholar
  15. Monick M, Staber J, Thomas K, Hunninghake G (2001) Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J Immunol 166:2681–2687CrossRefGoogle Scholar
  16. Nuki G (2008) Colchicine: its mechanism of action and efficacy in crystal–induced inflammation. Curr Rheumatol Rep 10:218–227CrossRefGoogle Scholar
  17. Rodríguez L, Cerbón-Ambriz J, Muñoz ML (1998) Effects of colchicine and colchiceine in a biochemical model of liver injury and fibrosis. Arch Med Res 29:109–116PubMedGoogle Scholar
  18. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW (2005) Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79:3350–3357CrossRefGoogle Scholar
  19. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ (1999) Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282:1440–1446CrossRefGoogle Scholar
  20. Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S (2015) Colchicine: old and new. Am J Med 128:461–470CrossRefGoogle Scholar
  21. Wang H, Peters N, Schwarze J (2006) Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 177:6263–6270CrossRefGoogle Scholar
  22. Wang YCYX, Yang X, Xing LH, Kong WZ (2013) Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication. World J Gastroenterol 19:5159–5164CrossRefGoogle Scholar
  23. Zeng R, Li C, Li N, Wei L, Cui Y (2011) The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma. Cytokine 53:1–7CrossRefGoogle Scholar

Copyright information

© King Abdulaziz City for Science and Technology 2019

Authors and Affiliations

  • Nihong Lu
    • 1
  • Yongrui Yang
    • 1
  • Honglu Liu
    • 1
  • Xiangli Ding
    • 2
  • Yangbing Ou
    • 1
  • Jiawei Xia
    • 1
  • Yingrong Du
    • 3
    Email author
  1. 1.Department of Respiratory MedicineThe Third People’s Hospital of Kunming CityKunmingChina
  2. 2.Department of Urinary SurgeryThe First Affiliated Hospital of Kunming Medical UniversityKunmingChina
  3. 3.Department of CardiovascularThe Third People’s Hospital of Kunming CityKunmingChina

Personalised recommendations